| Archive | |
| |
| 8 May 2006, Volume 94, Number 9 | |
| |
 | |
| Reviews | back to top |
| |
The place of VEGF inhibition in the current management of renal cell carcinoma P Nathan, D Chao, C Brock, P Savage, M Harries, M Gore & T Eisen for the London Biological & Targeted Therapy Group | |
| Abstract | Full Article | PDF |
1217 |
Adiponectin and cancer: a systematic review I Kelesidis, T Kelesidis & C S Mantzoros | |
| Abstract | Full Article | PDF |
1221 |
| |
| Clinical Studies | back to top |
| |
High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy M E de Jonge, A D R Huitema, J H Beijnen & S Rodenhuis | |
| Abstract | Full Article | PDF |
1226 |
Lactate dehydrogenase is not a useful marker for relapse in patients on surveillance for stage I germ cell tumours C Ackers & G J S Rustin | |
| Abstract | Full Article | PDF |
1231 |
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial C Pacilio, A Morabito, F Nuzzo, A Gravina, V Labonia, G Landi, E Rossi, E De Maio, M Di Maio, G D'aiuto, G Botti, N Normanno, P Chiodini, C Gallo, F Perrone & A de Matteis on behalf of the NCI-Naples Breast Cancer Group | |
| Abstract | Full Article | PDF |
1233 |
Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer S Kümmel, J Krocker, A Kohls, G-P Breitbach, G Morack, M Budner, J-U Blohmer & D Elling | |
| Abstract | Full Article | PDF |
1237 |
Baseline psychosocial predictors of survival in localised breast cancer U-S Lehto, M Ojanen, T Dyba, A Aromaa & P Kellokumpu-Lehtinen | |
| Abstract | Full Article | PDF |
1245 |
Psychological effects of a low-grade abnormal cervical smear test result: anxiety and associated factors N M Gray, L Sharp, S C Cotton, L F Masson, J Little, L G Walker, M Avis, Z Philips, I Russell, D Whynes, M Cruickshank & C M Woolley on behalf of the TOMBOLA group | |
| Abstract | Full Article | PDF |
1253 |
Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I-II study C Tibaldi, T Prochilo, F Russo, M C Pennucci, A Del Freo, F Innocenti, A Fabbri, A Falcone, P F Conte & E Baldini | |
| Abstract | Full Article | PDF |
1263 |
Phase II study of irinotecan combined with carboplatin in previously untreated small-cell lung cancer A Kinoshita, M Fukuda, H Soda, S Nagashima, M Fukuda, H Takatani, M Kuba, Y Nakamura, J Tsurutani, S Kohno & M Oka for the Nagasaki Thoracic Oncology Group (NTOG) | |
| Abstract | Full Article | PDF |
1267 |
Systematic review of factors influencing patient and practitioner delay in diagnosis of upper gastrointestinal cancer S Macdonald, U Macleod, N C Campbell, D Weller & E Mitchell | |
| Abstract | Full Article | PDF |
1272 |
A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma M E Burge, D Smith, C Topham, D P Jackson, D A Anthoney, F Halstead & M T Seymour | |
| Abstract | Full Article | PDF |
1281 |
A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patients M Mabro, P Artru, T André, M Flesch, F Maindrault-Goebel, B Landi, G Lledo, A Plantade, C Louvet & A de Gramont on behalf of GERCOR | |
| Abstract | Full Article | PDF |
1287 |
Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer U Graeven, B Kremer, Th Südhoff, B Killing, F Rojo, D Weber, J Tillner, C ünal & W Schmiegel | |
| Abstract | Full Article | PDF |
1293 |
| |
| Translational Therapeutics | back to top |
| |
RNA interference as a key to knockdown overexpressed cyclooxygenase-2 gene in tumour cells A Strillacci, C Griffoni, E Spisni, M C Manara & V Tomasi | |
| Abstract | Full Article | PDF |
1300 |
The  2 1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell linesJ J Grzesiak & M Bouvet | |
| Abstract | Full Article | PDF |
1311 |
| |
| Molecular Diagnostics | back to top |
| |
Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival A M Hanly, M Redmond, D C Winter, S Brophy, J M Deasy, D J Bouchier-Hayes & E W Kay | |
| Abstract | Full Article | PDF |
1320 |
Absence of p300 induces cellular phenotypic changes characteristic of epithelial to mesenchyme transition D Krubasik, N G Iyer, W R English, A A Ahmed, M Vias, C Roskelley, J D Brenton, C Caldas & G Murphy | |
| Abstract | Full Article | PDF |
1326 |
Oestrogen receptor and neoadjuvant therapy with tamoxifen: prediction of response and effects of treatmentW R Miller, T J Anderson, J M Dixon & P T K Saunders | |
| Abstract | Full Article | PDF |
1333 |
| |
| Epidemiology | back to top |
| |
Use of postmenopausal hormone replacement therapy and risk of non-Hodgkin's lymphoma: a Danish Population-based Cohort Study M Nørgaard, A H Poulsen, L Pedersen, H Gregersen, S Friis, M Ewertz, H E Johnsen & H T Sørensen | |
| Abstract | Full Article | PDF |
1339 |
Childhood leukaemia incidence around French nuclear installations using geographic zoning based on gaseous discharge dose estimates A-S Evrard, D Hémon, A Morin, D Laurier, M Tirmarche, J-C Backe, M Chartier & J Clavel | |
| Abstract | Full Article | PDF |
1342 |
| |
| Letters to the Editor | back to top |
| |
Mobile phone use and risk of acoustic neuroma: results of the interphone case-control study in five North European countries L Hardell & K Hansson Mild | |
| Abstract | Full Article | PDF |
1348 |
Mobile phone use and risk of acoustic neuroma B Hocking | |
| Abstract | Full Article | PDF |
1350 |
Mobile phone use and risk of glioma in adults: case-control study S Milham | |
| Abstract | Full Article | PDF |
1351 |
Reply: Mobile phone use and acoustic neuroma in five North European countries M J Schoemaker, A J Swerdlow, A Auvinen, E Cardis, M Feychting, C Johansen, P A McKinney & T Tynes | |
| Abstract | Full Article | PDF |
1352 |
| |
| Corrigendum | back to top |
| |
Mobile phone use and risk of glioma in adults: case-control study S Milham | |
| Abstract | Full Article | PDF |
1354 |
| In this issue | |
| ||
 | Reviews | |
| Clinical Studies | |
| Translational Therapeutics | |
| Molecular Diagnostics | |
| Epidemiology | |
| Letters to the Editor | |
| Corrigendum | |
| ||
| ||
| ||
 | Preceding issue | |
 | Next issue | |
| ||
| ||
| ||
|
| ||
| ||
 | ||
|
|
|
|
| |||
| Print ISSN: 0007-0920 | Online ISSN: 1532-1827 | © 2006 Cancer Research UK | ||
| |||
| Privacy Policy | |||